New Consortium To Monitor Whether COVID-19 Vaccines Work As They Should
Executive Summary
As the efficacy of most COVID-19 vaccines will likely be assessed using biomarkers and limited clinical data, monitoring their performance in the real-world is essential.
You may also be interested in...
EMA Commissions Research On Real-World Monitoring Of COVID-19 Vaccines
The European Medicines Agency is taking steps to establish infrastructure for monitoring COVID-19 vaccines whenever they reach the European market.
EU Guide Outlines Important Considerations For Submitting Complex Trials In CTIS
EU regulators have issued a new Q&A document on the key aspects that sponsors of complex trials should consider when making new submissions or moving ongoing studies to the Clinical Trials Information System.
UK’s Revamped Clinical Trials Framework To Offer Faster Application Review Timelines Than EU
The UK has finalized plans for delivering what it believes will be a stable and streamlined clinical trials framework following its departure from the EU. Transparency, patient involvement and diversity are high on the agenda.